| Enzymatic antioxidant system in vascular inflammation and coronary artery disease V Lubrano, S Balzan World journal of experimental medicine 5 (4), 218, 2015 | 177 | 2015 |
| Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays M Ferrandi, P Manunta, S Balzan, JM Hamlyn, G Bianchi, P Ferrari Hypertension 30 (4), 886-896, 1997 | 151 | 1997 |
| Consolidated and emerging inflammatory markers in coronary artery disease V Lubrano, S Balzan World journal of experimental medicine 5 (1), 21, 2015 | 144 | 2015 |
| LOX-1 receptor: A potential link in atherosclerosis and cancer S Balzan, V Lubrano Life Sciences 198, 79-86, 2018 | 119 | 2018 |
| LOX-1 and ROS, inseparable factors in the process of endothelial damage V Lubrano, S Balzan Free Radical Research 48 (8), 841-848, 2014 | 108 | 2014 |
| Roles of LOX-1 in microvascular dysfunction V Lubrano, S Balzan Microvascular Research 105, 132-140, 2016 | 66 | 2016 |
| Increased circulating levels of ouabain‐like factor in patients with asymptomatic left ventricular dysfunction S Balzan, D Neglia, S Ghione, G D'Urso, MC Baldacchino, U Montali, ... European journal of heart failure 3 (2), 165-171, 2001 | 60 | 2001 |
| Proangiogenic effect of TSH in human microvascular endothelial cells through its membrane receptor S Balzan, R Del Carratore, G Nicolini, P Beffy, V Lubrano, F Forini, ... The Journal of Clinical Endocrinology 97 (5), 1763-1770, 2012 | 58 | 2012 |
| Digoxin-like immunoreactivity in normal human plasma and urine, as detected by a solid-phase radioimmunoassay. S Balzan, A Clerico, M Grazia del Chicca, U Montali, S Ghione Clinical chemistry 30 (3), 450-451, 1984 | 57 | 1984 |
| New insights into mechanisms of cardioprotection mediated by thyroid hormones G Nicolini, L Pitto, C Kusmic, S Balzan, L Sabatino, G Iervasi, F Forini Journal of Thyroid Research 2013, 2013 | 50 | 2013 |
| Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor S Balzan, G D'Urso, S Ghione, A Martinelli, U Montali Life sciences 67 (16), 1921-1928, 2000 | 47 | 2000 |
| Role of oxidative stress-related biomarkers in heart failure: galectin 3, α1-antitrypsin and LOX-1: new therapeutic perspective? V Lubrano, S Balzan Molecular and cellular biochemistry 464 (1), 143-152, 2020 | 40 | 2020 |
| Angiopoietin 2 signal complexity in cardiovascular disease and cancer G Nicolini, F Forini, C Kusmic, G Iervasi, S Balzan Life sciences 239, 117080, 2019 | 39 | 2019 |
| Evidence for an endogenous ouabain-like immunoreactive factor in human newborn plasma coeluted with ouabain on HPLC V Di Bartolo, S Balzan, L Pieraccini, S Ghione, S Pegoraro, P Biver, ... Life sciences 57 (15), 1417-1425, 1995 | 39 | 1995 |
| New knowledge about old drugs: the anti-inflammatory properties of cardiac glycosides R Fürst, I Zündorf, T Dingermann Planta Medica 83 (12/13), 977-984, 2017 | 38 | 2017 |
| Presence of a functional TSH receptor on human erythrocytes S Balzan, G Nicolini, F Forini, G Boni, R Del Carratore, A Nicolini, A Carpi, ... Biomedicine & pharmacotherapy 61 (8), 463-467, 2007 | 36 | 2007 |
| Production of ouabain-like factor in normal and ischemic rat heart G D’Urso, S Frascarelli, S Balzan, R Zucchi, U Montali Journal of cardiovascular pharmacology 43 (5), 657-662, 2004 | 33 | 2004 |
| Digoxin-binding antibodies reverse the effect of endogenous digitalis-like compounds on Na, K-ATPase in erythrocytes S Balzan, U Montali, P Biver, S Ghione Journal of hypertension 9, S306, 1991 | 32 | 1991 |
| Erythrocyte sodium pump stimulation by ouabain and an endogenous ouabain-like factor. S Balzan, G D'Urso, G Nicolini, F Forini, M Pellegrino, U Montali Cell Biochemistry and Function 25 (3), 297-303, 2007 | 26 | 2007 |
| Endogenous ouabain and acute salt loading in low-renin hypertension S Balzan, G Nicolini, A Iervasi, PD Cecco, E Fommei American journal of hypertension 18 (7), 906-909, 2005 | 25 | 2005 |
